Capricor Therapeutics Inc. (NASDAQ:CAPR) has a beta value of 6.39 and has seen 1,056,917 shares traded in the last trading session. The company, currently valued at $105.55 Million, closed the last trade at $4.63 per share which meant it gained $0.09 on the day or 1.98% during that session. The CAPR stock price is -166.09% off its 52-week high price of $12.32 and 75.38% above the 52-week low of $1.14. If we look at the company’s 10-day average daily trading volume, we find that it stood at 173.28 Million shares traded. The 3-month trading volume is 956.28 Million shares.
The consensus among analysts is that Capricor Therapeutics Inc. (CAPR) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.
Capricor Therapeutics Inc. (NASDAQ:CAPR) trade information
Sporting 1.98% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Apr 29 when the CAPR stock price touched $5.30-1 or saw a rise of 12.64%. Year-to-date, Capricor Therapeutics Inc. shares have moved 34.99%, while the 5-day performance has seen it change 18.11%. Over the past 30 days, the shares of Capricor Therapeutics Inc. (NASDAQ:CAPR) have changed 0.22%. Short interest in the company has seen 872.19 Million shares shorted with days to cover at 0.91.
Wall Street analysts have a consensus price target for the stock at $12, which means that the shares’ value could jump 159.18% from current levels. The projected low price target is $12 while the price target rests at a high of $12. In that case, then, we find that the current price level is +159.18% off the targeted high while a plunge would see the stock lose 159.18% from current levels.
Capricor Therapeutics Inc. (CAPR) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +35.9% over the past 5 years. Earnings growth for 2021 is a modest +57.4%.
Capricor Therapeutics Inc. (NASDAQ:CAPR)’s Major holders
Insiders own 2.27% of the company shares, while shares held by institutions stand at 15.33% with a share float percentage of 15.69%. Investors are also buoyed by the number of investors in a company, with Capricor Therapeutics Inc. having a total of 31 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 343.01 Thousand shares worth more than $1.18 Million. As of December 30, 2020, Blackrock Inc. held 1.5% of shares outstanding.
The other major institutional holder is Vanguard Group Inc. (The), with the holding of over 305.6 Thousand shares as of December 30, 2020. The firm’s total holdings are worth over $1.05 Million and represent 1.34% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. As of December 30, 2020, the former fund manager holds about 1.29% shares in the company for having 293479 shares of worth $1.01 Million while later fund manager owns 104.76 Thousand shares of worth $643.23 Thousand as of February 27, 2021, which makes it owner of about 0.46% of company’s outstanding stock.